APA (7th ed.) Citation

Gou, L., Su, R., Guo, R., Li, L., Li, J., Zhou, B., . . . Li, H. (2025). Efficacy and safety of paliperidone palmitate 1-month formulation (PP1M) for schizophrenia in southwestern China. BMC Psychiatry, 25(1), 1. https://doi.org/10.1186/s12888-025-06646-1

Chicago Style (17th ed.) Citation

Gou, Lian, Rongcheng Su, Ruiqing Guo, Li Li, Jing Li, Bo Zhou, Lihong Huang, and Hui Li. "Efficacy and Safety of Paliperidone Palmitate 1-month Formulation (PP1M) for Schizophrenia in Southwestern China." BMC Psychiatry 25, no. 1 (2025): 1. https://doi.org/10.1186/s12888-025-06646-1.

MLA (9th ed.) Citation

Gou, Lian, et al. "Efficacy and Safety of Paliperidone Palmitate 1-month Formulation (PP1M) for Schizophrenia in Southwestern China." BMC Psychiatry, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12888-025-06646-1.